Clifford Sosin · Q2 2019
CAS Investment Partners
Portfolio at the end of Q2 2019, from the 13F filed August 14, 2019. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Carvana CVNA · history | 40.7% | Q1 2018 | No change |
| World Acceptance WRLD · history | 24.4% | Q4 2017 or earlier | Reduce 14% |
| Cardlytics CDLX · history | 14.4% | Q2 2019 | Buy |
| Herbalife HLF · history | 12.4% | Q4 2017 or earlier | No change |
| Credit Acceptance CACC · history | 8.1% | Q4 2017 or earlier | Reduce 39% |
| 5 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q1 2019, adjusted for stock splits.
Sector weighting
| Consumer discretionary | 40.7% | |
|---|---|---|
| Financials & real estate | 32.6% | |
| Technology | 14.4% | |
| Consumer staples | 12.4% |
What changed from Q1 2019
- Buy Cardlytics CDLX 14.4% of the 13F
- Reduce 14% World Acceptance WRLD 23.7% → 24.4%
- Reduce 39% Credit Acceptance CACC 14.6% → 8.1%